AAV production in insect cells in a chemically defined media platform
Adeno-associated viruses (AAVs) are the most commonly used viral vector for gene therapy applications and Spodoptera frugiperda (Sf9) cells are one of the cell lines predominantly used for AAV production. How can Lonza’s TheraPEAK® SfAAV® Medium help you to streamline and accelerate your AAV production in Sf9 cells?
This scientific poster describes how this medium allows for increased AAV production, consistent cell growth and reduced downstream purification, streamlining the process scale-up for the commercialization of gene therapies.